6^th World Congress on Medicinal Chemistry and Drug Design June 07-08, 2017 Milan,. Italy

Mario Ciampolini has completed his MD degree at the age of 25 years from Firenze University. He has been the director of the Unity of Gastroeneterology in the Pediatric Clinic of Firenze from the year 1966 to the retirement in the year 2000. He has published more than 50 papers in reputed journals and has been serving as an editorial board member of repute.

Medicinal Chemistry

Dr Radwan is a graduate of the U.K where he received his master & doctorate degrees from Middlesex business school in London .He also holds a first degree in Pharmacy & Pharmaceutical sciences from Cairo University.He is an Adjunct Professor of Management at Edinburgh Business School; Herriot Watt University in the UK. Ahmed is also the Chairman & CEO of PIONEERA HealthCare Group. He has over 25 years of experience within the pharmaceutical sector, including ethical pharmaceuticals, OTC, generics and strategic management consultation in the pharmaceutical field. His experience included French, German, Japanese, Swiss & British multinational pharmaceutical companies. Previous positions held; Marketing Director of Novartis, Regional Marketing Director of Otsuka and Regional Marketing Director of GSK. He also assumed the position of Managing Director at two major local companies .

Medicinal Chemistry, Biophysical Chemistry, Nanochemistry, Quantum Chemistry, Biomolecular and Vibrational Spectroscopy, Molecular Modeling and Structure, Theoretical, Computational and Mathematical Chemistry, Ab initio and Density Functional Methods

Dr Radwan is a graduate of the U.K where he received his master & doctorate degrees from Middlesex business school in London .He also holds a first degree in Pharmacy & Pharmaceutical sciences from Cairo University.He is an Adjunct Professor of Management at Edinburgh Business School; Herriot Watt University in the UK. Ahmed is also the Chairman & CEO of PIONEERA HealthCare Group. He has over 25 years of experience within the pharmaceutical sector, including ethical pharmaceuticals, OTC, generics and strategic management consultation in the pharmaceutical field. His experience included French, German, Japanese, Swiss & British multinational pharmaceutical companies. Previous positions held; Marketing Director of Novartis, Regional Marketing Director of Otsuka and Regional Marketing Director of GSK. He also assumed the position of Managing Director at two major local companies .

Biosimilars - Pharmaceutical Industry Trends - Generic Drugs - Strategic Pharmaceutical Management

Maia Merlani has completed her PhD from Tbilisi State University. She is Senior Research Scientist at Tbilisi State Medical University and at the same time holds a position of an Assistant Professor at Caucasian International University. Her field of interest is a chemistry and synthesis of natural compounds. She is the author of more than 45 papers in reputed journals and presentations at 55 international scientific conferences. She was granted Georgian Presidential scholarship for young scientists (1997), NATO scholarship (2002) and Matstumae International foundation scholarship (2013).

Medicinal Chemistry

Dr. Alexander Heifetz is Principal Scientist at Evotec (UK) Ltd, a drug discovery services company and visiting scientist at University College London at the group of Prof Andrea Townsend-Nicholson. Alex has more than 15 years of experience in drug discovery industry and was involved in discovery of 4 clinical drug candidates for treatment of anxiety, major depressive disorder, pulmonary hypertension, and Alzheimer’s disease. He has more than 35 patents and 40 publications in the area of medicinal chemistry. In 2011 he received the Royal Society Industry Award for development of methods for GPCR modeling. In 2001 he obtained his PhD from the Weizmann Institute of Science.

Materials Chemistry including Nanomaterials Materials Chemistry Nanoscience & Technology Medicinal Chemistry Electrochemistry Applied research in nanomaterials/ Process Development/Engineering Drug Design and Virtual Screening Controlled Drug Delivery Systems

Professor of Pesticides & Environmental Toxicology National Research Centre, Tahrir Str., Dokki, Cairo, Egypt (Chairman, National Committee of Toxicology, ASRT)

Pesticide, Environmental Toxicology

He is Dean of Central University of Gujarat, India

Medicinal Chemistry, Chemistry, Chemical science, Pharmaceutical Chemistry

Dr. Alexander Heifetz is Principal Scientist at Evotec (UK) Ltd, a drug discovery services company and visiting scientist at University College London at the group of Prof Andrea Townsend-Nicholson. Alex has more than 15 years of experience in drug discovery industry and was involved in discovery of 4 clinical drug candidates for treatment of anxiety, major depressive disorder, pulmonary hypertension, and Alzheimer’s disease. He has more than 35 patents and 40 publications in the area of medicinal chemistry. In 2011 he received the Royal Society Industry Award for development of methods for GPCR modeling. In 2001 he obtained his PhD from the Weizmann Institute of Science.

Medicinal Chemistry

Education M.Tech. Bioinformatics, Indian Institute of Information Technology-Allahabad, India M.Sc. University of Allahabad-Allahabad, India B.Sc. University of Allahabad-Allahabad, India Teaching experience Assistant Professor, Department of Biotechnology, Chhatrapati Shahu Ji Maharaj University, Kanpur (2011- till) Lecturer, Department of Bioinformatics, Chhatrapati Shahu Ji Maharaj University, Kanpur (2009-2011) Administrative experience Member, Advisory Board, National Service Scheme (NSS) Programme (2011-14), CSJM University, Kanpur Centre Representative and Observer in JEE B.Ed. -2010, 2011 and 2012 Counseling Centre Representative at CSJM University, Kanpur in JEE B.Ed. Counseling-2010, 2011 and 2012 Center Superintendent at IBSBT Center in University entrance Examination-2014

Chemi-informatics Computer-aided Drug designing Bioinformatics/ Data analysis Proteomics and Genomics